Ho KC - Search Results

1

Feasibility of Recombinant Human TSH as a Preparation for Radioiodine Therapy in Patients with Distant Metastases from Papillary Thyroid Cancer: Comparison of Long-Term Survival Outcomes with Thyroid Hormone Withdrawal.

Tsai HC, Ho KC, Chen SH, Tseng JR, Yang LY, Lin KJ, Cheng JC, Liou MJ. Tsai HC, et al. Among authors: ho kc. Diagnostics (Basel). 2022 Jan 17;12(1):221. doi: 10.3390/diagnostics12010221. Diagnostics (Basel). 2022. PMID: 35054388 Free PMC article.

2

Potential clinical role of 18F FDG-PET/CT in detecting hip prosthesis infection: a study in patients undergoing two-stage revision arthroplasty with an interim spacer.

Chen SH, Ho KC, Hsieh PH, Lee MS, Yen TC. Chen SH, et al. Among authors: ho kc. Q J Nucl Med Mol Imaging. 2010 Aug;54(4):429-35. Q J Nucl Med Mol Imaging. 2010. PMID: 20823810

3

The Synergy of ¹⁷⁷Lu-FAPI-046 with Tyrosine Kinase Inhibitor in a Sarcoma Patient-Derived Xenograft Mouse Model.

Tseng JR, Hsu CL, Hsieh HH, Ho KC, Chung YH, Wu CY. Tseng JR, et al. Among authors: ho kc. Biomed J. 2024 May 8:100744. doi: 10.1016/j.bj.2024.100744. Online ahead of print. Biomed J. 2024. PMID: 38729609 Free article.

4

Supraclavicular lymph node metastases in cervical cancer.

Qiu JT, Ho KC, Lai CH, Yen TC, Huang YT, Chao A, Chang TC. Qiu JT, et al. Among authors: ho kc. Eur J Gynaecol Oncol. 2007;28(1):33-8. Eur J Gynaecol Oncol. 2007. PMID: 17375703

5

Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.

Chao A, Ho KC, Wang CC, Cheng HH, Lin G, Yen TC, Lai CH. Chao A, et al. Among authors: ho kc. Gynecol Oncol. 2008 Aug;110(2):172-8. doi: 10.1016/j.ygyno.2008.03.018. Epub 2008 May 22. Gynecol Oncol. 2008. PMID: 18499238

6

Pretreatment Primary Tumor SUVmax on 18F-FDG PET/CT Images Predicts Outcomes in Patients With Salivary Gland Carcinoma Treated With Definitive Intensity-Modulated Radiation Therapy.

Hsieh CE, Ho KC, Hsieh CH, Yen TC, Liao CT, Wang HM, Lin CY. Hsieh CE, et al. Among authors: ho kc. Clin Nucl Med. 2017 Sep;42(9):655-662. doi: 10.1097/RLU.0000000000001740. Clin Nucl Med. 2017. PMID: 28650891

7

Prognostic factors and adjuvant therapy in uterine carcinosarcoma.

Wu TI, Hsu KH, Huang HJ, Hsueh S, Chou HH, Tsai CS, Ho KC, Chao A, Chang TC, Lai CH. Wu TI, et al. Among authors: ho kc. Eur J Gynaecol Oncol. 2008;29(5):483-8. Eur J Gynaecol Oncol. 2008. PMID: 19051818

8

Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence.

Ho KC, Wang CC, Qiu JT, Lai CH, Hong JH, Huang YT, Huang KG, Chao A, Lin G, Yen TC. Ho KC, et al. Gynecol Oncol. 2011 Nov;123(2):253-6. doi: 10.1016/j.ygyno.2011.07.020. Epub 2011 Jul 31. Gynecol Oncol. 2011. PMID: 21807401

9

TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.

Ho KC, Fang YD, Chung HW, Liu YC, Chang JW, Hou MM, Yang CT, Cheng NM, Su TP, Yen TC. Ho KC, et al. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2155-2165. doi: 10.1007/s00259-016-3433-2. Epub 2016 Jun 3. Eur J Nucl Med Mol Imaging. 2016. PMID: 27260520

10

Prognostic impact of combining whole-body PET/CT and brain PET/MR in patients with lung adenocarcinoma and brain metastases.

Ho KC, Toh CH, Li SH, Liu CY, Yang CT, Lu YJ, Su TP, Wang CW, Yen TC. Ho KC, et al. Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):467-477. doi: 10.1007/s00259-018-4210-1. Epub 2018 Nov 10. Eur J Nucl Med Mol Imaging. 2019. PMID: 30415280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page